|
Volumn 25, Issue 8, 2001, Pages 289-290
|
The National Schizophrenia Fellowship on treatment guidelines
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
NEW DRUG;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
MENTAL DISEASE;
MENTAL HEALTH;
NATIONAL HEALTH SERVICE;
NOTE;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
SCHIZOPHRENIA;
SIDE EFFECT;
|
EID: 0034870841
PISSN: 09556036
EISSN: None
Source Type: Journal
DOI: 10.1192/pb.25.8.289 Document Type: Note |
Times cited : (2)
|
References (3)
|